CAS: 1058137-23-7 - Lucitanib
Formula:C26H25N3O4
InChI:InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)
InChI key:InChIKey=CUDVHEFYRIWYQD-UHFFFAOYSA-N
SMILES:O=C(NC)C1=CC=CC2=CC(OC=3C=CN=C4C=C(OCC5(N)CC5)C(OC)=CC43)=CC=C21
- Synonyms:
- 1-Naphthalenecarboxamide, 6-[[7-[(1-aminocyclopropyl)methoxy]-6-methoxy-4-quinolinyl]oxy]-N-methyl-
- Lucitanib
- 6-[[7-[(1-Aminocyclopropyl)methoxy]-6-methoxy-4-quinolinyl]oxy]-N-methyl-1-naphthalenecarboxamide
- AL 3810
- E 3810
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Lucitanib REF: TM-T15185CAS: 1058137-23-7 | 96.13% | 47.00 €~694.00 € | Tue 07 Jan 25 | |
E-3810 REF: IN-DA008TFOCAS: 1058137-23-7 | 98% | To inquire | Tue 07 Jan 25 | |
Lucitanib REF: 10-F979141CAS: 1058137-23-7 | 98.94% | To inquire | Tue 14 Jan 25 | |
Lucitanib REF: 3D-ISB13723CAS: 1058137-23-7 | Min. 95% | To inquire | Tue 18 Feb 25 |
Lucitanib
CAS:1058137-23-7
Lucitanib (E-3810) is a VEGFR/FGFR inhibitor targeting VEGFR1-3 and FGFR1-2 with IC50s 7-82.5 nM.
Formula:
C26H25N3O4
Purity:
96.13%
Color and Shape:
Solid
Molecular weight:
443.49
Ref: TM-T15185
1mg | 47.00 € | ||
2mg | 62.00 € | ||
5mg | 96.00 € | ||
10mg | 142.00 € | ||
25mg | 265.00 € | ||
50mg | 479.00 € | ||
100mg | 694.00 € | ||
1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: IN-DA008TFO
1mg | 125.00 € | ||
25mg | 154.00 € | ||
50mg | 260.00 € | ||
100mg | 585.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 10-F979141
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Lucitanib
CAS:1058137-23-7
Lucitanib is a potent anti-tumor agent that inhibits the growth of cancer cells by inhibiting …
Formula:
C26H25N3O4
Purity:
Min. 95%
Molecular weight:
443.49 g/mol
Ref: 3D-ISB13723
10mg | 308.00 € | ||
100mg | 1,155.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025